前端編輯

管理員身份可於登入後,進行網站的前端管理。

Platelet activation and aggregation underlie acute thrombosis that leads to ST-elevation myocardial infarction (STEMI). L5—highly electronegative low-density lipoprotein (LDL)—is significantly elevated in patients with STEMI. Thus, we examined the role of L5 in thrombogenesis. Plasma LDL from patients with STEMI (n 5 30) was chromatographically resolved into 5 subfractions (L1-L5) with increasing electronegativity. In vitro, L5 enhanced adenosine diphosphate–stimulated platelet aggregation twofold more than did L1 and induced platelet-endothelial cell (EC) adhesion. L5 also increased P-selectin expression and glycoprotein (GP)IIb/IIIa activation and decreased cyclic adenosine monophosphate levels (n 56, P < .01) in platelets. In vivo, injection of L5 (5mg/kg) into C57BL/6 mice twice weekly for 6 weeks shortened tail bleeding time by 43%(n5 3; P < .01 vs L1-injected mice) and increased P-selectin expression and GPIIb/IIIa activation in platelets. Pharmacologic blockade experiments revealed that L5 signals through platelet activating factor receptor and lectin-like oxidized LDL receptor-1 to attenuate Akt activation and trigger granule release and GPIIb/IIIa activation via protein kinase C-a. L5 but not L1 induced tissue factor and P-selectin expression in human aortic ECs (P < .01), thereby triggering platelet activation and aggregation with activated ECs. These findings indicate that elevated plasma levels of L5 may promote thrombosis that leads to STEMI. (Blood. 2013;122(22):3632-3641)

 
Blood 2013-F7
 
附件下載
FileFile sizeLast modified
Download this file (0-201311-Blood-sup.pdf)Blood 2013-sup90 kB2014-07-31
Download this file (0-201311-Blood.pdf)Blood 20131891 kB2014-07-31
Download this file (Blood 2013-F7.ppt)Blood 2013 Figure 7239 kB2014-07-31
Go to top